Efficacy of thalidomide in the treatment of refractory ankylosing spondylitis

Arthritis and Rheumatism

Volumn 42, Issue 3, 1999, Pages 580-581

  Breban, Maxime ^a   Gombert, Bruno ^a   Amor, Bernard ^a   Dougados, Maxime ^a  

^a Univ René Descartes ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

THALIDOMIDE;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; MALE; PRIORITY JOURNAL; RECURRENT DISEASE;

ADULT; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; SPONDYLITIS, ANKYLOSING; THALIDOMIDE;

EID: 0033051561     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199904)42:3<580::AID-ANR27>3.0.CO;2-D     Document Type: Article

References (8)

1. Amor B, Dougados M, Khan MA. Management of refractory ankylosing spondylitis and related spondylarthropathies. Rheum Dis Clin North Am 1995;21:117-28.
2. Braun J, Bollow M, Neure L, Seipelt E, Seyrekbasan F, Herbst H, et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 1995;38:499-505.
3. Moreira AL, Sampaio EP, Zmuidzinas A, Frindt P, Smith KA, Kaplan G. Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J Exp Med 1993;177:1675-80.
4. Moller DR, Wysocka M, Greenlee BM, Ma X, Wahl L, Flockhart DA, et al. Inhibition of IL-12 production by thalidomide. J Immunol 1997;159:5157-61.
5. Klausner JD, Freedman VH, Kaplan G. Thalidomide as an anti-TNF-alpha inhibitor: implications for clinical use. Clin Immunol Immunopathol 1996;81:219-23.
6. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
7. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
8. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21:2281-5.